June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss
Relationship Enhancement Better sexual function and increased desire can have positive effects on intimate relationships and overall connection with your partner
These injections combine the power of vitamin B12 with lipotropic nutrients that assist in breaking down fat deposits in the body
2025 milestone: Combined Mounjaro and Zepbound sales of $36.5 billion made tirzepatide the worlds best-selling drug in 2025 surpassing Novo Nordisks combined semaglutide portfolio ($33 billion) and Mercks Keytruda ($31.7 billion)
Does freezing and thawing BPC-157 really damage it
Personalized Guidance: Genetic Testing and Contraceptive Metabolism The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways